China Pharmaceuticals & Healthcare Q3 2019
China remains one of the most attractive APAC markets for innovative drugmakers. In the coming years, the Chinesepharmaceutical market will grow modestly with medicine sales driven an ageing population and high disease burden. Newregulatory pathways and improvements to China’s drug approval process will bolster long-term growth opportunities fordrugmakers. Although this is favourable to innovative drugmakers, patented drug sales will be limited by the government’s drugpricing and reimbursement policies as well as other cost-containment measures.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook